The fact that a lower intratumoral expression of ADCK2, as well as MYL6, in melanoma is connected with a poor prognosis for melanoma patients allows the conclusion that ADCK2 might be a tumor suppressor in melanoma. Here, MYL6 is linked to neoplasm.